Kenneth Galbraith has joined Ventures West as a venture partner focused on life sciences opportunities. Last year he served as chairman and interim CEO of AnorMED, until its $600 million cash sale to Genzyme. www.ventureswest.com
Kenneth Galbraith has joined Ventures West as a venture partner focused on life sciences opportunities. Last year he served as chairman and interim CEO of AnorMED, until its $600 million cash sale to Genzyme. www.ventureswest.com
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.